Elanco Animal Health Incorporated Common Stock earnings per share and revenue
On Feb 24, 2026, ELAN reported earnings of 0.13 USD per share (EPS) for Q4 25, beating the estimate of 0.11 USD, resulting in a 15.04% surprise. Revenue reached 1.14 billion, compared to an expected 1.11 billion, with a 2.62% difference. The market reacted with a +6.59% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 13 analysts forecast an EPS of 0.35 USD, with revenue projected to reach 1.31 billion USD, implying an increase of 169.23% EPS, and increase of 14.88% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Aveanna Healthcare Holdings Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
$0.13
Actual
$0.17
Surprise
+19.05%
FAQ
What were Elanco Animal Health Incorporated Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Elanco Animal Health Incorporated Common Stock reported EPS of $0.13, beating estimates by 15.04%, and revenue of $1.14B, 2.62% above expectations.
How did the market react to Elanco Animal Health Incorporated Common Stock's Q4 2025 earnings?
The stock price moved up 6.59%, changed from $24.75 before the earnings release to $26.38 the day after.
When is Elanco Animal Health Incorporated Common Stock expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Elanco Animal Health Incorporated Common Stock's next earnings report?
Based on 13
analysts, Elanco Animal Health Incorporated Common Stock is expected to report EPS of $0.35 and revenue of $1.31B for Q1 2026.